4.7 Article

Potential intervariant and intravariant recombination of Delta and Omicron variants

期刊

JOURNAL OF MEDICAL VIROLOGY
卷 94, 期 10, 页码 4830-4838

出版社

WILEY
DOI: 10.1002/jmv.27939

关键词

Delta-Omicron XD; Omicron; recombination; SARS-CoV-2

类别

资金

  1. Microbial Pathogenesis Training Grant [AI7323-31]
  2. UCLA AIDS Institute
  3. UCLA David Geffen School of Medicine -Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Award Program
  4. US National Institute of Health funds [AI069120, AI158154, AI149718, AI155232]
  5. China postdoctoral science foundation grants [2020T130007ZX]
  6. Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2021-PT180-001]
  7. CAMS Innovation Fund for Medical Sciences [2021-I2M-1-061]
  8. National Natural Science Foundation of China [92169106]
  9. National Key Plan for Scientific Research and Development of China [2021YFC2301305]
  10. Youthful Teacher Project of Peking Union Medical College [3332019114]
  11. Suzhou science and technology development plan [szs2020311]

向作者/读者索取更多资源

The study provides evidence of intervariant and intravariant recombination of rapidly evolving SARS-CoV-2 genomes, suggesting potential for more infectious, immune-escaping, and disease-causing Omicron and Delta-Omicron variants.
Among numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concerns, Omicron is more infectious and immune-escaping, while Delta is more pathogenic. Here, we provide evidence for both intervariant and intravariant recombination of the rapidly evolving new SARS-CoV-2 genomes, including XD/XE/XF and BA.3, raising concerns of potential more infectious, immune-escaping, and disease-causing Omicron and Delta-Omicron variants.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据